Comments
Commented by Fabian Lorenz on September 8th, 2025 | 07:05 CEST
Top news and price target raised! Plug Power, Standard Lithium, and BMW partner European Lithium
In the run-up to the IAA, BMW is stealing the spotlight from other automakers. The focus of attention is clearly on the Munich-based company's "Neue Klasse". If the new electric models are a success, European Lithium stands to benefit - they are set to supply the lithium for the batteries. But this raw materials gem has a second ace up its sleeve: rare earths. The stock is being driven by positive news flow, which is likely to continue. Standard Lithium is also seeing strong momentum. Analysts have recently raised their price targets significantly. In contrast, the alarm lights continue to flash at Plug Power. While revenue is rising and costs are falling, cash burn remains a concern. Nevertheless, analysts are recommending the hydrogen stock as a "Buy".
Read
Commented by Nico Popp on September 8th, 2025 | 07:00 CEST
Trillion-dollar market for tokenized securities: Stock market newcomer Finexity, Deutsche Börse, Coinbase
Blockchain offers transparency and efficiency—it is no surprise that digital assets are considered the next evolutionary stage of capital markets. Studies predict a market volume in the double-digit trillions by 2030. Boston Consulting, for example, is talking about a market volume of USD 16 trillion by 2030. The race for market share includes the major stock exchange operators as well as savings banks and fintechs. Finexity, a pioneer in digital assets, has now gone public - a company that has significantly shaped developments in recent years and is well-positioned for the future. We shed light on the prospects for Finexity and explain how far along competitors like Deutsche Börse and Coinbase already are.
Read
Commented by Fabian Lorenz on September 5th, 2025 | 07:15 CEST
GOLD EXPLOSION to USD 5,000? Barrick Mining, Sranan Gold, and First Majestic Silver! Better than Rheinmetall?
While experts predict prices of over EUR 2,200 for Rheinmetall, they believe gold could reach USD 5,000 per ounce. This puts mining stocks back in the spotlight after lagging behind the precious metal's performance for a long time. Barrick Mining is showing signs of life and has begun a recovery after several challenging years. However, things could get even more exciting for explorers, such as Sranan Gold. The Company is attractively valued, and following high-grade sampling, a drilling program has just been launched. This drill program benefits from historical data from gold giant Iamgold. Meanwhile, the price of silver is also picking up again and now stands at over USD 40. First Majestic Silver is delivering exploration results that support its growth potential.
Read
Commented by Nico Popp on September 5th, 2025 | 07:10 CEST
"Olive-Green Economic Miracle" – Who stands to benefit? Volatus Aerospace, Hensoldt, AeroVironment
Germany's Federal Minister of Economic Affairs, Katherina Reiche, sees great potential for the German economy in military rearmament. An article in Handelsblatt even refers to it as an "olive-green economic miracle." But who will benefit most from the billions in spending over the coming years? In addition to traditional defense companies, smaller niche providers and startups are also raring to go. We explain which stocks will truly benefit from this "olive-green economic miracle."
Read
Commented by André Will-Laudien on September 5th, 2025 | 07:05 CEST
Trump under pressure, markets wobble – Technically position now with BYD, Almonty, and Palantir for the next 100% gains!
The stock markets are in yet another bubble, but unlike the tech bubble in 2000, investors are more prepared for the impending correction. The warning signs could not be more evident: inflation, wars, numerous global conflicts, surging interest rates, massive deficits, tariffs and trade wars! Anyone who sees short-term growth under these conditions is likely mistaken. And yet, the market is still holding on to the megatrends of artificial intelligence and defense. Admittedly, 1,000% or more could be earned here, which is good for those who rode out these trends. But caution is advised: The Shiller P/E ratio for the S&P 500 rose above 40 last week – well above the historical norm of 12 to 25. So, where is the celebration continuing? We offer a few clues.
Read
Commented by Nico Popp on September 4th, 2025 | 07:25 CEST
AI reaches medicine – Here is where it has the greatest impact: NetraMark, Siemens Healthineers, Intuitive Surgical
AI is revolutionizing more and more industries. A recent article in Handelsblatt highlights the enormous potential in medicine and names Siemens Healthineers and Intuitive Surgical as the beneficiaries. AI would significantly increase the often-lacking efficiency in industry. According to Handelsblatt, citing analysts from Fortune Business Insights, the market for AI in healthcare could grow by 44% annually to USD 504 billion by 2032. We show where the greatest leverage exists and which companies are still small enough to benefit disproportionately from developments in the coming years.
Read
Commented by Armin Schulz on September 4th, 2025 | 07:20 CEST
BYD under fire: How First Hydrogen, SMR Technology, and Nel ASA aim to disrupt the Hydrogen Market
The mobility of the future will be shaped by more than just one technology. While electric batteries dominate in passenger vehicles, hydrogen offers enormous potential in heavy-duty transport, light commercial vehicles, and industrial applications. Its breakthrough depends on affordable, green production. Innovative small modular reactors (SMRs) could be the game changer here, radically reducing costs and guaranteeing long-term production. In this context, we take a closer look at BYD, the industry leader in electric mobility. First Hydrogen has already tested hydrogen-powered vehicles on the road and is now increasingly focusing on SMR development. Last but not least, we analyze hydrogen veteran Plug Power.
Read
Commented by Nico Popp on September 4th, 2025 | 07:15 CEST
Tariff shock for Trump, Concerns about US banks, Gold hype: Globex Mining, Newmont, Bank of America
In recent months, many feared the US was on a path toward dictatorship. Fortunately, this is not yet the case, as demonstrated recently by a US federal appeals court ruling, which declared 75% of Donald Trump's tariffs to be illegal. The judges involved ruled independently of their political leanings – both supporters and opponents of the tariffs included Republicans and Democrats. While this is not such a bad thing for US political culture, it does harbour enormous risks: tariffs worth billions could now be reversed, and the US Federal Reserve may once again delay its planned interest rate cuts. One clear beneficiary of this uncertainty has been gold, with the precious metal reaching a new all-time high. We highlight the opportunities.
Read
Commented by Fabian Lorenz on September 4th, 2025 | 07:10 CEST
Rheinmetall shares above EUR 2,200? SELL SMA Solar? dynaCERT with SALES SUCCESS!
Could Rheinmetall shares surpass EUR 2,200 following a potential acquisition? Analysts consider this possible after taking a closer look at the Company's opportunities in the marine sector. There is even talk of a potential takeover battle with another German company. Meanwhile, sales are picking up at dynaCERT. An initial large order is expected to strengthen its distribution partnership in the Americas. If the success stories continue, higher share prices are on the cards for the cleantech company. The situation is quite different at SMA Solar. After a significant profit warning and millions in write-downs, the Company is sliding deep into the red. Analysts are lowering their price targets and see no buying opportunity even after the recent price slump.
Read
Commented by Nico Popp on September 4th, 2025 | 07:05 CEST
What comes after the weight loss injection? How does BioNxt intend to outperform Eli Lilly and Novo Nordisk?
The weight loss injection is all the rage. Not only are celebrities shedding significant pounds with it, but many people in our own circles are also losing weight effortlessly thanks to modern GLP-1 receptor agonists. Many patients report that they simply do not feel hungry anymore. This is already having an impact on the restaurant industry in the US – people are ordering more salads and splitting desserts. With Wegovy and similar drugs, one to two teaspoons of tiramisu is enough. But this billion-dollar market is far from reaching all patients. What groundbreaking developments in modern weight loss drugs are already in the pipeline, and how can investors benefit?
Read